Health Care & Life Sciences » Pharmaceuticals | AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
119.03 M
Public Float
90.33 M
AVEO Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.34
Market Cap
$109.62 M
Shares Outstanding
160.74 M
Public Float
100.48 M

Profile

Address
One Broadway
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.aveooncology.com
Updated 07/08/2019
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. The company was founded by Ronald A.

Financials

View All

Michael P. Bailey
President, Chief Executive Officer & Director
John H. Johnson
Director